Evaluation of Myeloid and Lymphoid Regulatory Cell Populations in the Peripheral Blood of Patients Receiving GM-CSF in a Vaccine-Based Immunotherapy Clinical Trial

被引：0
|
作者：
Olson, Walter C. [1 ]
McSkimming, Chantel [1 ]
Slingluff, Craig L. [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：872 / 873
页数：2
相关论文
共 50 条
  • [31] Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy
    Hutchison, S.
    Sahay, B.
    de Mello Souza, C. H.
    Sayour, E. J.
    Lejeune, A.
    Szivek, A.
    Livaccari, A. M.
    Fox-Alvarez, S.
    Salute, M.
    Powers, L.
    Milner, R. J.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2019, 216
  • [32] Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF
    Gasparetto, C
    Gasparetto, M
    Morse, M
    Rooney, B
    Vredenburgh, JJ
    Long, GD
    Rizzieri, DA
    Loftis, J
    Chao, NJ
    Smith, C
    CYTOKINE, 2002, 18 (01) : 8 - 19
  • [33] Analysis of naive and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine
    Hueman, Matthew T.
    Stojadinovic, Alexander
    Storrer, Catherine E.
    Dehqanzada, Zia A.
    Gurney, Jennifer M.
    Shriver, Craig D.
    Ponniah, Sathibalan
    Peoples, George E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (02) : 135 - 146
  • [34] CFU-GM CAPACITY, ENGRAFTMENT, AND LONG-TERM GRAFT FUNCTION: A COMPARISON OF THREE METHODS OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL MOBILIZATION (G-CSF, G-CSF plus PLERIXAFOR, OR CYCLOPHOSPHAMIDE plus G/GM-CSF) IN PATIENTS RECEIVING SIMILAR CD34+ CELL DOSES
    Alexander, E. T.
    Towery, J. A.
    Squires, J. E.
    Kramer, C.
    Stuart, R. K.
    Costa, L. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S218 - S218
  • [35] Phase II trial of vaccination with WT1 peptide, GM-CSF, and KLH in patients with acute myeloid leukemia and myelodysplasia: Final immunological, molecular, and clinical results
    Letsch, A.
    Scheibenbogen, C.
    Busse, A.
    Asemissen, A. M.
    Schmittel, A.
    Hofmann, W. K.
    Uharek, L.
    Blau, I. W.
    Thiel, E.
    Keilholz, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] MULTI-TIME POINT EVALUATION OF PERIPHERAL BLOOD MYELOID-DERIVED SUPPRESSOR CELL AND LYMPHOCYTE POPULATIONS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING ADJUVANT THERAPY
    Sloan, Lindsey
    Sen, Rupashree
    Doucet, Michele
    Blosser, Lee
    Shpitser, Ilya
    Sherman, Eli
    San, Numair
    Cheng, Zhi
    Katulis, Lisa
    Wemmer, Jan
    Kamson, David
    Jackson, Christina
    Hu, Chen
    McNutt, Todd
    Grossman, Stuart
    Holdhoff, Matthias
    Lim, Michael
    Redmond, Kristin J.
    Eberhart, Charles
    Quon, Harry
    Pardoll, Drew
    Ganguly, Sudipto
    Kleinberg, Lawrence
    NEURO-ONCOLOGY, 2019, 21 : 283 - 283
  • [37] Selective in vivo mobilization with GM-CSF of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation
    Avigan, D
    Gong, JL
    Wu, ZK
    Wheeler, C
    Joyce, R
    Levine, J
    Elias, A
    Richardson, P
    Demetri, G
    Milano, J
    Anderson, K
    Kufe, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 86 - 86
  • [38] Phase I clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients
    Head, Jonathan F.
    Daniels, Gregory A.
    McKinney, Michelle
    Ongkeko, Weg
    Sakamoto, Kyoko
    Wang-Rodriguez, Jessica
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [39] A randomized prospective study of peripheral blood stem cell (PBSC) mobilization with cyclophosphamide (CTX) in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF, in non-hodgkin's lymphoma (NHL) patients: Co-mobilization of dendritic cells and NK cells.
    Gazitt, Y
    Fey, V
    Shaughnessy, P
    Devore, P
    BLOOD, 1999, 94 (10) : 637A - 637A
  • [40] GM-CSF secreting leukemia cell vaccinations after allogeneic reduced intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML).
    Ho, Vincent
    Dranoff, Glenn
    Kim, Haesook
    Pasek, Mildred
    Cutler, Corey
    Alyea, Edwin
    Koreth, John
    Antin, Joseph H.
    Soiffer, Robert J.
    BLOOD, 2006, 108 (11) : 1052A - 1052A
12345